Establishment of the Daucus carota SMC-1 Cell Suspension Line for Poliovirus Vaccine Development
Planta Medica · 01.01.2024 · 90 (01) · 63-72
DOI: 10.1055/a-2181-2886 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.01.2024. Verfasst von Mónica Morales-Aguilar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación en Biotecnología, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, Mexico. Hauptthemen laut MEDLINE: Daucus carota, Poliovirus, Poliovirus Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Consejo Nacional de Ciencia y Tecnología.
Abstract (Originalsprache)
The development of virus-free, oral vaccines against poliovirus capable of inducing mucosal protective immunity is needed to safely combat this pathogen. In the present study, a carrot cell line expressing the poliovirus VP2 antigen was established at the level of callus and cell suspensions, exploring the effects of culture media (MS and B5), supplementation with urea, phytoregulators (2,4-D : KIN), and light conditions (continuous light, photoperiod, and total darkness). The best callus growth was obtained on B5 medium supplemented with 2 mg/L of 2,4-D + 2 mg/L kinetin and 0.0136 g/L of urea and in continuous light conditions. Suspension cultures of the SMC-1 line in 250 mL Erlenmeyer flasks had a maximum growth of 16.07 ± 0.03 g/L DW on day 12 with a growth rate of µ=0.3/d and a doubling time of 2.3 days. In a 2 L airlift bioreactor, the biomass yield achieved was 25.6 ± 0.05 g/L DW at day 10 with a growth rate of µ= 0.58/d and doubling time of 1.38 d. Cell growth was 1.5 times higher in bioreactors than in shake flasks, highlighting that both systems resulted in the accumulation of VP2 throughout the time in culture. The maximum VP2 yield in flasks was 387.8 µg/g DW at day 21, while in the reactor it was 550.2 µg/g DW at day 18. In conclusion, bioreactor-based production of the VP2 protein by the SMC-1 suspension cell line offers a higher productivity when compared to flask cultures, offering a key perspective to produce low-cost vaccines against poliomyelitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centro de Investigación en Biotecnología, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, Mexico.
- Laboratorio de Biofarmacéuticos Recombinantes, Universidad Autónoma de San Luis Potosí, SLP, Mexico.
- Sección de Biotecnología, Centro de Investigación en Ciencias de la Salud y Biomedicina (CICSaB), Universidad Autónoma de San Luis Potosí, Mexico.
Förderung
- Consejo Nacional de Ciencia y Tecnología
Zitieren
APA
Morales-Aguilar, M., Bolaños-Martínez, O. C., Maldonado, A. R., Govea-Alonso, D. O., Carreño-Campos, C., Villarreal, M. L., Rosales-Mendoza, S., & Ortiz-Caltempa, A. (2024). Establishment of the Daucus carota SMC-1 Cell Suspension Line for Poliovirus Vaccine Development. Planta Medica, 90(01), 63-72. https://doi.org/10.1055/a-2181-2886
Vancouver
Morales-Aguilar M, Bolaños-Martínez OC, Maldonado AR, Govea-Alonso DO, Carreño-Campos C, Villarreal ML, et al. Establishment of the Daucus carota SMC-1 Cell Suspension Line for Poliovirus Vaccine Development. Planta Medica. 2024;90(01):63-72. doi:10.1055/a-2181-2886
BibTeX
@article{MoralesAguilar2024,
author = {Morales-Aguilar, Mónica and Bolaños-Martínez, Omayra Citlalli and Maldonado, Andrea Romero and Govea-Alonso, Dania O and Carreño-Campos, Christian and Villarreal, María Luisa and Rosales-Mendoza, Sergio and Ortiz-Caltempa, Anabel},
title = {Establishment of the Daucus carota SMC-1 Cell Suspension Line for Poliovirus Vaccine Development},
journal = {Planta Medica},
year = {2024},
volume = {90},
number = {01},
pages = {63--72},
doi = {10.1055/a-2181-2886}
}
EUVIMED